197 results on '"Hau, Eric"'
Search Results
2. Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study
3. SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life
4. Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy
5. Homologous recombination promotes mitotic death to suppress the innate immune response
6. A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC)
7. Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort
8. Adapting to change: exploring perceptions and demands of the coronavirus (COVID-19) workforce changes – an Australian multi-institutional radiation oncology survey.
9. First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study
10. A Wnt-mediated phenotype switch along the epithelial–mesenchymal axis defines resistance and invasion downstream of ionising radiation in oral squamous cell carcinoma
11. Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial
12. Correction to: Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
13. Functional perfusion image guided radiation treatment planning for locally advanced lung cancer
14. Changes in Brain Metastasis During Radiosurgical Planning
15. Short Diffusion Time Diffusion-Weighted Imaging With Oscillating Gradient Preparation as an Early Magnetic Resonance Imaging Biomarker for Radiation Therapy Response Monitoring in Glioblastoma: A Preclinical Feasibility Study
16. Stereotactic Ablative Body Radiotherapy for Early NSCLC: Changes in Pulmonary Function, Dyspnoea and Quality of Life
17. 2174: Single versus multi-fraction SABR for early-stage primary lung and pulmonary oligometastases.
18. Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas
19. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
20. Table S1 from Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
21. Data from Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
22. Resistance of Glioblastomas to Radiation Therapy
23. Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer
24. What genes predict response to neoadjuvant chemoradiation in locally advanced rectal cancer? A systematic review based on gene expression profiling.
25. Use of durvalumab in stage III n on‐small ‐cell lung cancer based on eligibility for the PACIFIC study
26. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial
27. Immunotherapy, radiation oncology and radiology: An alliance into the future
28. Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment
29. Radiation therapy in the prevention and management of brain metastases in patients with small cell lung cancer: a narrative review
30. Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study.
31. Radiotherapy Breast Boost With Reduced Whole-Breast Dose Is Associated With Improved Cosmesis: The Results of a Comprehensive Assessment From the St. George and Wollongong Randomized Breast Boost Trial
32. Fractionated Stereotactic Radiosurgery Following Surgery for Brain Metastases: A Single Australian Centre Experience and Literature Review.
33. DDRE-07. TARGETING TUMOR HYPOXIA AND MITOCHONDRIAL METABOLISM WITH ANTI-PARASITIC DRUGS AS AN APPROACH TO IMPROVE THE RADIOSENSITIVITY OF DIFFUSE INTRINSIC PONTINE GLIOMA
34. EXTH-41. IMPROVING THE RADIOSENSITIVITY OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) BY TARGETING HYPOXIA AND MITOCHONDRIAL METABOLISM
35. Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation
36. Implementation of the Australian Computer‐Assisted Theragnostics (AusCAT) network for radiation oncology data extraction, reporting and distributed learning
37. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas
38. Additional file 1 of Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial
39. The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial
40. Recommendations for the aesthetic evaluation of breast cancer conservative treatment
41. Potential benefits and pitfalls of respiratory-gated radiotherapy in the treatment of thoracic malignancy
42. Breast irradiation causes pallor in the nipple-areolar complex in women with Celtic skin type (result from the St. George and Wollongong randomised breast boost trial)
43. MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review
44. Minimal benefit of respiratory-gated radiation therapy in the management of thoracic malignancy
45. DIPG-13. TARGETING HYPOXIA AND MITOCHONDRIA WITH REPURPOSED METABOLIC DRUGS AS AN APPROACH TO RADIOSENSITIZATION FOR DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)
46. Radiotherapy treatment for lung cancer: Current status and future directions
47. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
48. Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia
49. Abstract 4864: Targeted melanoma therapies as radiosensitizers
50. DIPG-17. IMPROVING THE RADIOSENSITIVITY OF DIFFUSE INTRINSIC PONTINE GLIOMAS BY MODULATING BIOENERGETIC PATHWAYS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.